Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts

Xenotransplantation

Volumn 21, Issue 6, 2014, Pages 510-522

  Barone, Angela ^a   Benktander, John ^b   Teneberg, Susann ^b   Breimer, Michael E ^a  

^a SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

carbohydrate antigens; glycosphingolipid characterization; immune recognition of bioprosthetic heart valves; mass spectrometry; porcine heart valves

Indexed keywords

FUCOSYLGANGLIOTETRAOSYLCERAMIDE; GANGLIOSIDE; GLOBOTETRAOSYLCERAMIDE; GLYCOSPHINGOLIPID; H PENTAOSYLCERAMIDE TYPE 2; LECTIN; MONOCLONAL ANTIBODY; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; SULFATIDE; UNCLASSIFIED DRUG; NEURAMINIC ACID DERIVATIVE;

ANIMAL TISSUE; ANTIGEN BINDING; AORTA VALVE; ARTICLE; HEART GRAFT; IMMUNE RESPONSE; LECTIN BINDING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PULMONARY VALVE; SWINE; THIN LAYER CHROMATOGRAPHY; ANIMAL; BIOPROSTHESIS; HEART VALVE; HEART VALVE PROSTHESIS; ORGAN TRANSPLANTATION; PIG; PROCEDURES; SURGERY; XENOGRAFT;

ACIDIC GLYCOSPHINGOLIPIDS; ANIMALS; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVES; NEURAMINIC ACIDS; ORGAN TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84916606670     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12123     Document Type: Article

References (41)

1. Manji RA, Ekser B, Menkis AH, Cooper DK,. Bioprosthetic heart valves of the future. Xenotransplantation 2014; 21: 1-10. Epub 2014/01/22.
2. Heinzerling RH, Stein PD, Riddle JM, Magilligan DJ Jr, Jennings JJ,. Immunological involvement in porcine bioprosthetic valve degeneration: preliminary studies. Henry Ford Hosp Med J 1982; 30: 146-151. Epub 1982/01/01.
3. Moczar M, Houel R, Ginat M, et al. Structural changes in porcine bioprosthetic valves of a left ventricular assist system in human patients. J Heart Valve Dis 2000; 9: 88-95; discussion -6. Epub 2000/03/04.
4. Human P, Zilla P,. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001; 71 (5 Suppl): S385-S388. Epub 2001/06/05.
5. Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006; 114: 318-327. Epub 2006/07/13.
6. Breimer ME,. Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era. Xenotransplantation 2011; 18: 215-228. Epub 2011/08/19.
7. Joziasse DH, Shaper JH, Van den Eijnden DH, Van Tunen AJ, Shaper NL,. Bovine alpha 1-3-galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA. J Biol Chem 1989; 264: 14290-14297. Epub 1989/08/25.
8. Uemura K, Yuzawa M, Taketomi T,. Characterization of major glycolipids in bovine erythrocyte membrane. J Biochem 1978; 83: 463-471. Epub 1978/02/01.
9. Chien JL, Li SC, Li YT,. Isolation and characterization of a heptaglycosylceramide from bovine erythrocyte membranes. J Lipid Res 1979; 20: 669-673. Epub 1979/07/01.
10. Konakci KZ, Bohle B, Blumer R, et al. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest 2005; 35: 17-23. Epub 2005/01/11.
11. Park S, Kim WH, Choi SY, Kim YJ,. Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A. J Korean Med Sci 2009; 24: 1126-1131. Epub 2009/12/02.
12. Choi SY, Jeong HJ, Lim HG, et al. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves. J Heart Valve Dis 2012; 21: 387-397. Epub 2012/07/20.
13. Kasimir MT, Rieder E, Seebacher G, et al. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng 2005; 11: 1274-1280. Epub 2005/09/08.
14. Naso F, Gandaglia A, Iop L, Spina M, Gerosa G,. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater 2011; 7: 1728-1734. Epub 2010/12/02.
15. Naso F, Gandaglia A, Bottio T, et al. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. Xenotransplantation 2013; 20: 252-261. Epub 2013/07/20.
16. Mangold A, Szerafin T, Hoetzenecker K, et al. Alpha-Gal specific IgG immune response after implantation of bioprostheses. Thorac Cardiovasc Surg 2009; 57: 191-195. Epub 2009/08/12.
17. Bloch O, Golde P, Dohmen PM, et al. Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves. Tissue Eng Part A 2011; 17: 2399-2405. Epub 2011/05/12.
18. Park CS, Oh SS, Kim YE, et al. Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults. J Heart Valve Dis 2013; 22: 222-229. Epub 2013/06/27.
19. Breimer ME, Hansson GC, Karlsson KA, Leffler H,. Glycosphingolipids and the differentiation of intestinal epithelium. Exp Cell Res 1981; 135: 1-13. Epub 1981/09/01.
20. Karlsson KA,. Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies. Methods Enzymol 1987; 138: 212-220. Epub 1987/01/01.
21. Waldi D,. Sprühreagentien für die dünnschicht-chromatographie. Dûnnschicht-chromatographie Berlin: Springer-Verlag, 1962; 496-515.
22. Svennerholm L, Fredman P,. A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta 1980; 617: 97-109. Epub 1980/01/18.
23. Folch J, Lees M, Sloane Stanley GH,. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509. Epub 1957/05/01.
24. Karlsson H, Halim A, Teneberg S,. Differentiation of glycosphingolipid-derived glycan structural isomers by liquid chromatography/mass spectrometry. Glycobiology 2010; 20: 1103-1116. Epub 2010/05/15.
25. Hansson GC, Karlsson KA, Larson G, et al. Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay. J Biol Chem 1983; 258: 4091-4097. Epub 1983/04/10.
26. Angstrom J, Teneberg S, Karlsson KA,. Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes. Proc Natl Acad Sci USA 1994; 91: 11859-11863. Epub 1994/12/06.
27. Teneberg S, Angstrom J, Jovall PA, Karlsson KA,. Characterization of binding of Gal beta 4GlcNAc-specific lectins from Erythrina cristagalli and Erythrina corallodendron to glycosphinogolipids. Detection, isolation, and characterization of a novel glycosphinglipid of bovine buttermilk. J Biol Chem 1994; 269: 8554-8563. Epub 1994/03/18.
28. Hsu FF, Turk J,. Studies on sulfatides by quadrupole ion-trap mass spectrometry with electrospray ionization: structural characterization and the fragmentation processes that include an unusual internal galactose residue loss and the classical charge-remote fragmentation. J Am Soc Mass Spectrom 2004; 15: 536-546. Epub 2004/03/30.
29. Ito E, Tominaga A, Waki H, et al. Structural characterization of monosialo-, disialo- and trisialo-gangliosides by negative ion AP-MALDI-QIT-TOF mass spectrometry with MS(n) switching. Neurochem Res 2012; 37: 1315-1324. Epub 2012/03/07.
30. Ito M, Yamagata T,. Purification and characterization of glycosphingolipid-specific endoglycosidases (endoglycoceramidases) from a mutant strain of Rhodococcus sp. Evidence for three molecular species of endoglycoceramidase with different specificities. J Biol Chem 1989; 264: 9510-9519. Epub 1989/06/05.
31. Holgersson J, Jovall PA, Samuelsson BE, Breimer ME,. Structural characterization of non-acid glycosphingolipids in kidneys of single blood group O and A pigs. J Biochem 1990; 108: 766-777. Epub 1990/11/01.
32. Diswall M, Angstrom J, Schuurman HJ, et al. Studies on glycolipid antigens in small intestine and pancreas from alpha1,3-galactosyltransferase knockout miniature swine. Transplantation 2007; 84: 1348-1356. Epub 2007/12/01.
33. Diswall M, Angstrom J, Karlsson H, et al. Structural characterization of alpha1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation 2010; 17: 48-60. Epub 2010/02/13.
34. Stone KR, Abdel-Motal UM, Walgenbach AW, Turek TJ, Galili U,. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation 2007; 83: 211-219. Epub 2007/02/01.
35. Filippo N, Paola A, Laura I, Michele S, Gino G,. Biocompatibility Evaluation Criteria for Novel Xenograft Materials: Distribution and Quantification of Remnant Nucleic Acid and Alpha-Gal Epitope. J Stem Cell Res Ther 2013; S6: 009. doi: 10.4172/2157-7633.S6-009.
36. McGregor CG, Carpentier A, Lila N, Logan JS, Byrne GW,. Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. J Thorac Cardiovasc Surg 2011; 141: 269-275. Epub 2010/12/21.
37. Ariga T, Sekine M, Yu RK, Miyatake T,. Isolation and characterization of a novel disialoganglioside from bovine adrenal medulla. Arch Biochem Biophys 1984; 232: 305-309. Epub 1984/07/01.
38. Nakao T, Kon K, Ando S, Hirabayashi Y,. A NeuGc-containing trisialoganglioside of bovine brain. Biochim Biophys Acta 1991; 1086: 305-309. Epub 1991/11/27.
39. Teneberg S, Willemsen PT, de Graaf FK, et al. Characterization of gangliosides of epithelial cells of calf small intestine, with special reference to receptor-active sequences for enteropathogenic Escherichia coli K99. J Biochem 1994; 116: 560-574. Epub 1994/09/01.
40. Hojny J,. H blood group genotypes and expression of A and O antigens in pigs. Anim Blood Groups Biochem Genet 1974; 5: 3-10. Epub 1974/01/01.
41. Coddens A, Diswall M, Angstrom J, et al. Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli. J Biol Chem 2009; 284: 9713-9726. Epub 2009/02/12.